NCT04278768 2026-03-19Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)Curis, Inc.Phase 1/2 Suspended366 enrolled
NCT06761677 2026-02-05A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell LymphomaSymBio PharmaceuticalsPhase 1/2 Suspended43 enrolled